| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 01/06/2011 | WO2011001088A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | WO2011000945A2 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| 01/06/2011 | WO2011000863A1 Sulfonamide derivatives for use in the treatment of skin conditions |
| 01/06/2011 | WO2010129057A3 Tetracycline compounds |
| 01/06/2011 | WO2009057133A3 A process for the synthesis of 2-[2-[4-[(4-chlorophenyl)phenyl methyl]-1-piperazinyl] ethoxy acetic acid |
| 01/06/2011 | US20110003993 Salt of (2s, 3s) -3- [ [ (1s) -1- isobutoxymethyl-3-methylbutyl] carbamyl] oxirane-2-carboxylic acid |
| 01/06/2011 | US20110003991 Piperazine derivatives and their use in controlling pests |
| 01/06/2011 | US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/06/2011 | US20110003784 Opsin-binding ligands, compositions and methods of use |
| 01/06/2011 | US20110002992 N-sulphonylated amino acid derivatives, method for the production and use thereof |
| 01/06/2011 | CA2769210A1 Michael addition reaction product and active energy ray-curable composition |
| 01/06/2011 | CA2766873A1 Therapeutic compositions and related methods of use |
| 01/06/2011 | CA2764193A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | CA2764185A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/05/2011 | EP2270002A1 Quinazoline derivatives as histamine H4-receptor inhibitors for use in the treatment of inflammatory disorders |
| 01/05/2011 | EP2268619A1 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 01/05/2011 | EP2268612A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 01/05/2011 | EP2268605A1 Fatty acid derivatives for oral administration endowed with high paia- tability |
| 01/05/2011 | CN101939306A Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 01/05/2011 | CN101935311A Piperazinium trifluoroacetate compound and carbon dioxide absorbent using the same |
| 01/04/2011 | US7863441 cyclization using phosphorus oxychloride; antipsychotic or neuroleptic agent for psychological disorders |
| 01/04/2011 | US7863332 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics |
| 01/04/2011 | US7863272 Therapy for stroke, cancer, multiple sclerosis, brain disorders, Parkinson's disease, Huntington's diseasee |
| 01/04/2011 | CA2601149C Process of producing amorolfine |
| 01/04/2011 | CA2501388C Nitroaniline-based alkylating agents and their use as prodrugs |
| 01/04/2011 | CA2488363C O-substituted hydroxyaryl derivatives |
| 01/04/2011 | CA2479362C N-sulfonylurea apoptosis promoters |
| 01/04/2011 | CA2435908C Aromatic derivatives as hiv aspartyl protease inhibitors |
| 01/04/2011 | CA2421228C Polyarylcarboxamides useful as lipid lowering agents |
| 01/04/2011 | CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 12/30/2010 | US20100331345 Derivatives of substituted tartaric acid and usage for preparing beta-secretase inhibitors |
| 12/30/2010 | US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors |
| 12/30/2010 | US20100331234 Aminoalcohol lipidoids and uses thereof |
| 12/30/2010 | US20100326277 Piperazinium trifluoroacetate compound and carbon dioxide absorbent using the same |
| 12/29/2010 | WO2010150192A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof |
| 12/29/2010 | WO2010148422A1 Compounds and methods for treating parasitic infestations |
| 12/29/2010 | EP2266968A2 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 12/29/2010 | EP2266955A1 Mutilin derivatives and their use as pharmaceutical |
| 12/29/2010 | EP2266951A1 Organic compounds |
| 12/29/2010 | EP1595863B1 Quaternary ammonium salts |
| 12/29/2010 | EP1292573B1 Substituted thioacetamides |
| 12/29/2010 | CN101928284A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 12/29/2010 | CN101928265A 1-(cinnamoyl)-4-alkyl amide piperazine compound and preparation method thereof |
| 12/29/2010 | CN101928264A Apoptosis promoters |
| 12/29/2010 | CN101928263A Method for preparing efletirizine dihydrochloride |
| 12/29/2010 | CN101928226A N-(2-ethoxy) feriilamidoethyl nitrate compound and preparation method thereof |
| 12/29/2010 | CA2766104A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof |
| 12/28/2010 | US7858777 comprises the ring closure and deprotection of an intermediate; 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f]-1,4-thiazepine; used as an antipsychotic or neuroleptic |
| 12/23/2010 | WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators |
| 12/23/2010 | WO2010146173A1 Quinazoline derivatives as histamine h4-recept0r inhibitors for use in the treatment of inflammatory disorders |
| 12/23/2010 | WO2010145037A1 Disubstituted-aminodifluorosulfinium salts, process for preparing same and method of use as deoxofluorination reagents |
| 12/23/2010 | WO2009147389A8 Processes for the synthesis of levocetirizine and intermediates for use therein |
| 12/23/2010 | US20100324291 Processes for 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof |
| 12/23/2010 | US20100324140 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/23/2010 | US20100324064 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders |
| 12/23/2010 | US20100324025 Antibacterial Agents |
| 12/23/2010 | CA2767895A1 Opsin-binding ligands, compositions and methods of use |
| 12/23/2010 | CA2764241A1 Disubstituted-aminodifluorosulfinium salts, process for preparing same and method of use as deoxofluorination reagents |
| 12/22/2010 | EP2262784A1 Inhibitors of the chemokine receptor cxcr3 |
| 12/22/2010 | CN1729158B Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/22/2010 | CN101925573A Novel N-(2-amino-phenyl)-amide derivatives |
| 12/22/2010 | CN101921247A 1-(cinnamoyl)-4-piperidyl amide piperazidine compound and preparation method thereof |
| 12/22/2010 | CN101921246A Monomer compound comprising several cationic groups and process for making the same |
| 12/22/2010 | CN101921184A Multi-functional group type aromatic ketone compound and photoinitiator containing same |
| 12/22/2010 | CN101481362B Method for preparing hexamethylene imine |
| 12/22/2010 | CN101318909B Benzoyl fluoride benzene salicylamide compounds, preparation and application thereof |
| 12/21/2010 | US7855297 Amide derivatives and medicinal use thereof |
| 12/21/2010 | US7855230 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine |
| 12/21/2010 | US7855198 Benzamide derivative or salt thereof |
| 12/21/2010 | US7854854 Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device |
| 12/21/2010 | CA2464130C Mch antagonists for the treatment of obesity |
| 12/21/2010 | CA2406255C Hydroxylamine esters as polymerization initiators |
| 12/21/2010 | CA2294924C Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 12/16/2010 | WO2010144371A1 Alkanoylamino benzamide aniline hdac inihibitor compounds |
| 12/16/2010 | WO2010142810A1 Synthesis of hydrazines from hydroxylamine-o-sulphonic acid |
| 12/16/2010 | WO2010142650A1 Novel cyclopentane derivatives |
| 12/16/2010 | US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties |
| 12/16/2010 | US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer |
| 12/16/2010 | US20100317582 Novel cyclic hydrocarbon compounds for the treatment of diseases |
| 12/16/2010 | CA2763786A1 Alkanoylamino benzamide aniline hdac inihibitor compounds |
| 12/16/2010 | CA2762619A1 Novel cyclopentane derivatives |
| 12/15/2010 | EP2261208A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 12/15/2010 | EP2261207A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 12/15/2010 | EP2259865A1 Aromatic halsulfonyl isocyanate compositions and polymers therefrom |
| 12/15/2010 | EP1756037B1 Amino alcohol derivatives and their activity as renin inhibitors |
| 12/15/2010 | CN101918384A Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| 12/15/2010 | CN101914036A Method for preparing azobenzene derivatives |
| 12/15/2010 | CN101914031A Pregabalin derivative and application thereof |
| 12/15/2010 | CN101912382A 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 12/15/2010 | CN101230015B Substituted cinnamic acid derivatives containing amine substituent group and tumor cytotoxicity thereof |
| 12/15/2010 | CN101220009B Method for producing N-amido piperidine hydrochlorate |
| 12/15/2010 | CN101068789B Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole |
| 12/14/2010 | US7851642 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compound |
| 12/14/2010 | US7851627 Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates |
| 12/14/2010 | US7851505 for the treatment of diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or nuclear factor kappa beta dysregulation |
| 12/14/2010 | US7851488 Tetrahydropyridines with central nervous system activity |
| 12/14/2010 | US7851487 Use of tetrahydropyridines in the treatment of central nervous system disorders |
| 12/14/2010 | US7851474 Dipiperazinyl ketones and related analogues |
| 12/14/2010 | US7851411 α-Cyanoacrylates |